Bio-Connect
Human IGFBP7 PicoKine ELISA Kit standard curve
Human IGFBP7 PicoKine ELISA Kit standard curve
Human IGFBP7 PicoKine ELISA Kit standard curve

Human IGFBP7 PicoKine ELISA Kit

EK0991
Boster Bio
ReactivityHuman
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human IGFBP7 PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    625 pg/ml - 40,000 pg/ml
  • Assay Sensitivity
    <20 pg/ml
  • Assay Time
    15-20
  • Certification
    Research Use Only
  • Scientific Description
    Human IGFBP7/Igfbp Rp1 ELISA Kit PicoKine® (96 Tests). Quantitate Human IGFBP7 in cell culture supernatants, serum, plasma (heparin, EDTA) and urine. Sensitivity: 20pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity
    Human
  • Reactivity Supplier
    Human IGFBP7
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • de Rooij ENM, Hoogeveen EK, Romijn FPHTM, et al. Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors. Sci Rep. 2024,14(1):12901. doi: 10.1038/s41598-024-62246-1
    Read this paper
  • Obata Y, Kamijo-Ikemori A, Shimmi S, et al. Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. Sci Rep. 2023,13(1):18569. doi: 10.1038/s41598-023-46015-0
    Read this paper
  • Krejčová G, Morgantini C, Zemanová H, et al. Macrophage-derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection. EMBO J. 2023,42(23):e114086. doi: 10.15252/embj.2023114086
    Read this paper
  • van Duijl TT, Ruhaak LR, van Kooten C, et al. Multiplex LC-MS/MS Testing for Early Detection of Kidney Injury: A Next-Generation Alternative to Conventional Immunoassays? J Appl Lab Med. 2022,7(4):923-930. doi: 10.1093/jalm/jfac024
    Read this paper
  • Okuda H, Obata Y, Kamijo-Ikemori A, et al. Quantitative and qualitative analyses of urinary L-FABP for predicting acute kidney injury after emergency laparotomy. J Anesth. 2022,36(1):38-45. doi: 10.1007/s00540-021-03003-w
    Read this paper
  • Esmeijer K, Schoe A, Ruhaak LR, et al. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery. Sci Rep. 2021,11(1):1071. doi: 10.1038/s41598-020-80196-2
    Read this paper
  • Chen C, Tian X, Zhao X, et al. Clinical study of serum IGFBP7 in predicting lymphatic metastasis in patients with lung adenocarcinoma. Curr Probl Cancer. 2020,44(6):100584. doi: 10.1016/j.currproblcancer.2020.100584
    Read this paper
  • Bank JR, Ruhaak R, Soonawala D, et al. Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients. Transplantation. 2019,103(5):1014-1023. doi: 10.1097/TP.0000000000002472
    Read this paper
  • Benassi MS, Pazzaglia L, Novello C, et al. Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma. Am J Cancer Res. 2015,5(11):3446-54.
    Read this paper